Literature DB >> 77217

[Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].

G H Jacobi, J E Altwein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 77217     DOI： 10.1055/s-0028-1104520

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  2 in total

1.  Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.

Authors:  G H Jacobi; J E Altwein; R Hohenfellner
Journal:  Klin Wochenschr       Date:  1979-01-01

2.  The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.

Authors:  L Jeromin
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.